Abstract
Sodium-glucose cotransporter-2 (SGLT2) is a sodium-dependent glucose transport protein, and its inhibitors (SGLT2i - gliflozins) are indicated as an adjunct therapy to diet and exercise for improving glycemic control in type 2 diabetes mellitus (DM2). In fact, SGLT2i usage has been associated with a
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have